Ligand validation:9I6I

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9I6I_LFA_D_313	67%	69%	0.117	0.953	0.3	0.86	-	-	0	0	85%	1
9I6I_LFA_C_309	47%	69%	0.166	0.905	0.29	0.88	-	-	1	0	100%	1
9I6I_LFA_D_311	41%	69%	0.175	0.888	0.29	0.9	-	-	0	0	100%	1
9I6I_LFA_D_312	39%	69%	0.177	0.885	0.29	0.9	-	-	0	0	100%	1
9I6I_LFA_E_311	35%	70%	0.168	0.91	0.31	0.82	-	-	1	0	70%	1
9I6I_LFA_E_310	35%	73%	0.138	0.931	0.3	0.73	-	-	0	0	40%	1
9I6I_LFA_D_316	25%	75%	0.163	0.917	0.31	0.65	-	-	0	0	35%	1
9I6I_LFA_A_317	25%	69%	0.181	0.849	0.28	0.9	-	-	2	0	80%	1
9I6I_LFA_E_314	24%	75%	0.167	0.914	0.31	0.66	-	-	0	0	35%	1
9I6I_LFA_C_308	24%	73%	0.179	0.916	0.3	0.73	-	-	0	0	40%	1
9I6I_LFA_A_313	23%	72%	0.169	0.902	0.3	0.77	-	-	0	0	40%	1
9I6I_LFA_B_309	23%	73%	0.175	0.905	0.3	0.72	-	-	0	0	40%	1
9I6I_LFA_B_311	20%	73%	0.181	0.897	0.29	0.73	-	-	0	0	35%	1
9I6I_LFA_E_313	15%	78%	0.197	0.894	0.31	0.57	-	-	0	0	25%	1
9I6I_LFA_B_313	14%	71%	0.196	0.831	0.3	0.79	-	-	0	0	55%	1
9I6I_LFA_D_315	14%	78%	0.212	0.889	0.32	0.57	-	-	0	0	30%	1
9I6I_LFA_E_316	14%	72%	0.202	0.842	0.3	0.78	-	-	2	0	50%	1
9I6I_LFA_C_313	14%	77%	0.178	0.851	0.3	0.61	-	-	0	0	30%	1
9I6I_LFA_D_314	13%	74%	0.2	0.854	0.3	0.69	-	-	1	0	35%	1
9I6I_LFA_B_310	12%	71%	0.225	0.845	0.3	0.79	-	-	0	0	50%	1
9I6I_LFA_C_311	11%	70%	0.197	0.864	0.4	0.75	-	-	0	0	20%	1
9I6I_LFA_B_314	9%	71%	0.245	0.81	0.3	0.79	-	-	0	0	55%	1
9I6I_LFA_A_316	8%	78%	0.244	0.848	0.31	0.57	-	-	0	0	30%	1
9I6I_LFA_A_314	8%	73%	0.27	0.852	0.3	0.73	-	-	1	0	40%	1
9I6I_LFA_E_303	7%	70%	0.31	0.828	0.3	0.84	-	-	3	0	70%	1
9I6I_LFA_A_318	6%	72%	0.231	0.77	0.3	0.78	-	-	0	0	45%	1
9I6I_LFA_B_308	6%	73%	0.255	0.794	0.31	0.73	-	-	1	0	45%	1
9I6I_LFA_C_310	6%	77%	0.241	0.799	0.31	0.61	-	-	1	0	25%	1
9I6I_LFA_E_312	5%	70%	0.329	0.879	0.41	0.72	-	-	0	0	20%	1
9I6I_LFA_A_312	5%	75%	0.286	0.807	0.3	0.68	-	-	0	0	35%	1
9I6I_LFA_C_314	4%	78%	0.289	0.812	0.32	0.56	-	-	0	0	25%	1
9I6I_LFA_A_315	4%	70%	0.249	0.78	0.4	0.75	-	-	0	0	20%	1
9I6I_LFA_E_315	1%	78%	0.31	0.662	0.31	0.58	-	-	1	0	30%	1
9I6H_LFA_C_309	61%	69%	0.136	0.926	0.29	0.88	-	-	0	0	100%	1
6RF6_LFA_A_307	50%	79%	0.101	0.904	0.23	0.62	-	-	0	0	70%	1
4XTL_LFA_A_315	46%	89%	0.079	0.949	0.26	0.38	-	-	1	0	25%	1
4XTN_LFA_J_311	43%	74%	0.092	0.958	0.38	0.61	-	-	1	0	20%	1
6XYT_LFA_C_309	41%	100%	0.165	0.878	0.07	0.05	-	-	0	0	100%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.